CD7 and CD28 are T cell Ig superfamily molecules that share common signaling mechanisms. To determine roles CD7 and CD28 might play in peripheral lymphocyte development and function, we have generated CD7/CD28-double-deficient mice. CD7-and CD28-single-deficient and CD7/CD28-double-deficient mice had normal levels of CD4 and CD8-single-positive T cells in thymus and spleen. However, CD28-deficient mice had decreased CD4 ؉ CD25 ؉ T cells in spleen compared with wild-type mice, and CD7/CD28-double-deficient mice had decreased numbers of CD4 ؉ CD25 ؉ T cells in both thymus and spleen compared with both wild-type and CD28-deficient mice. Functional studies demonstrated that CD4 ؉ CD25 ؉ T cells from CD28-deficient and CD7/ CD28-double-deficient mice could mediate suppression of CD3 mAb activation of CD4 ؉ CD25 ؊ wild-type T cells, but were less potent than wild-type CD4 ؉ CD25 ؉ T regulatory cells. Thyroiditis developed in aged CD7/CD28-double-deficient mice (>1 year) that was not seen in age-matched control mice or single CD7-or CD28-deficient mice, thus suggesting in vivo loss of T regulatory cells allowed for the development of spontaneous thyroiditis. Taken together, these data demonstrated collaborative roles for both CD7 and CD28 in determination of number and function of CD4 ؉ CD25 ؉ T regulatory cells in the thymus and peripheral immune sites and in the development of spontaneous thyroiditis.
T he CD28 molecule is a 44-kDa homodimeric member of the Ig gene superfamily (1) (2) (3) that is expressed on thymocytes, ϳ95% of peripheral CD4 ϩ T cells, and ϳ50% of peripheral CD8 ϩ T cells (3, 4) . Triggering of CD28 by B7.1 and/or B7.2 on APCs enhances TCR T cell triggering, cytokine production, and effector functions (3, (5) (6) (7) (8) . Analysis of CD28deficient animals has demonstrated that CD28 confers an enhanced ability to expand the peripheral T cell pool (9) and is important in augmenting peripheral production of IL-2, IFN-␥, and TNF-␣ (10 -12) .
CD7 is a 40-kDa member of the Ig gene superfamily that is expressed in T and NK cells (13) . CD7 signals through phosphatidylinositol 3-kinase, induces TCR␥␦ and NK cell IL-2, TNF-␣, and IFN-␥ production, and up-regulates cell adhesion molecule expression (13) . Recent work has shown that the natural ligand for CD7 is a secreted molecule of epithelial, polymorphonuclear, and macrophage lineage cells called K-12 or SECTM-1 (14) . In mice, the role of CD7 in activating T and NK cells is not well described due to lack of availability of anti-murine CD7 mAbs. However, CD7 deficiency in mice results in Ag-specific T cell triggering defects and defective generation of Ag-specific CTL (15) and protection from LPS-induced shock syndrome (16) .
We have recently reported the generation of CD7/CD28-doubledeficient mice and described the combined impact of CD7 and CD28 deficiency on murine thymocyte development and function (17) . CD7/CD28-double-deficient animals were healthy, repro-duced normally, had normal numbers of thymocyte subsets, and had normal thymus histology. However, CD7 and CD28 deficiencies combined to produce decreased numbers of B7.1/B7.2-expressing cells in the thymus, decreased thymocyte IL-2R expression (CD25), and decreased thymocyte CD3-triggered cytokine production (17) .
CD4 ϩ CD25 ϩ T regulatory cells are a unique lineage of thymusderived cells that have immune suppressive effects on effector T cell function in vitro and in vivo. These cells represent ϳ5-10% of peripheral murine CD4 ϩ T cells, constitutively express the ␣-chain of the IL-2R (CD25), and mediate suppression of T cell activation by CD3 mAbs or allogeneic cells (18 -20) . Mice depleted of T regulatory cells by a variety of mechanisms develop organ-specific autoimmune diseases such as thyroiditis, gastritis, and inflammatory bowel disease (21) .
Expression of CD28 has been shown to be important for maintaining the numbers of peripheral CD4 ϩ CD25 ϩ T regulatory cells and for suppressing the development of diabetes in nonobese diabetic mice (22) . However, the role of CD7 and its interaction with CD28 in immune regulation is unknown. In this study, we demonstrate that addition of CD7 deficiency to CD28 deficiency significantly decreased the number of CD4 ϩ CD25 ϩ T cells in the thymus and spleen. Although the CD4 ϩ CD25 ϩ T cells that are present in CD7/CD28-deficient mice have suppressive activity, the potency of CD4 ϩ CD25 ϩ T regulatory cells in CD7/CD28-deficient mice was less than that of T regulatory cells in wild-type mice. Moreover, the combined deficiency of both CD7 and CD28 resulted in spontaneous thyroiditis in 1-to 2-year-old animals that was not observed in age-matched control mice.
Isolation of CD4 ϩ CD25 Ϫ and CD4 ϩ CD25 ϩ T cells
Two protocols were used to isolate CD4 ϩ CD25 Ϫ and CD4 ϩ CD25 ϩ T cells from wild-type and deficient animals for in vitro functional assays. The first protocol enriched effector and regulatory T cells from lymph node cells using T Cell Enrichment Columns (R&D Systems, Minneapolis, MN) and Miltenyi beads (Miltenyi Biotec, Auburn, CA). The second protocol obtained high-purity populations of T cells by FACS.
For the enrichment protocol, T cells were isolated from lymph node cell suspensions using commercial T Cell Enrichment Columns (R&D Systems). CD4 ϩ T cells were then isolated with the Miltenyi CD4 ϩ T cell isolation system and separated using LS columns according to the manufacturer's specifications (Miltenyi Biotec). The CD4 ϩ T cells were counted, washed, centrifuged (1500 rpm for 5 min), and incubated (30 min, 4°C) in Miltenyi MACS buffer with saturating amounts of rat anti-mouse CD25-PE Ab (clone PC61; BD PharMingen, San Diego, CA). Cells were washed with MACS buffer before centrifugation (1500 rpm for 5 min). The cells were incubated (20 min, 4°C) with anti-PE microbeads (Miltenyi Biotec), washed, and centrifuged in MACS buffer before placing on MS columns (Miltenyi Biotech). CD4 ϩ CD25 Ϫ T cells were collected, centrifuged (1500 rpm for 5 min), and resuspended in complete medium. CD4 ϩ CD25 ϩ T cells were eluted from the MS columns with MACS buffer, centrifuged, and counted. The purity of each enriched cell population was determined by immunophenotyping/flow cytometry and for CD4 ϩ CD25 Ϫ cells was: C57BL/6 (93 Ϯ 6%, n ϭ 7), CD7 deficient (92 Ϯ 9%, n ϭ 7), CD28 deficient (92 Ϯ 9%, n ϭ 5), and CD7/CD28 deficient (97 Ϯ 1%, n ϭ 4) and for CD4 ϩ CD25 ϩ cells was: C57BL/6 (47 Ϯ 16%, n ϭ 7), CD7 deficient (47 Ϯ 7%, n ϭ 7), CD28 deficient (33 Ϯ 6%, n ϭ 5), and CD7/CD28 deficient (24 Ϯ 9%, n ϭ 4).
For the FACS protocol, lymph node cell suspensions were enriched for CD4 ϩ T cells as described above. The CD4 ϩ T cells from each mouse strain were counted, washed, centrifuged (1500 rpm for 5 min), and incubated (30 min, 4°C) in azide-free PBS plus 1% BSA with saturating amounts of rat anti-mouse CD25-PE and CD4-PE-CyChrome Abs (BD PharMingen). Cells were washed with azide-free PBS plus 1% BSA buffer before FACS separation at 4°C into CD4 ϩ CD25 Ϫ and CD4 ϩ CD25 ϩ frac-tions on a FACSVantage SE-Diva flow cytometer (BD Biosciences). Cells were counted, spun down, and resuspended in 4°C complete medium at 10 6 cells/ml for functional assays. The purity of each enriched cell population was determined by immunophenotyping/flow cytometry and for CD4 ϩ CD25 Ϫ cells was: C57BL/6 (95 Ϯ 3%, n ϭ 4), CD28 deficient (98 Ϯ 2%, n ϭ 3), and CD7/CD28 deficient (97 Ϯ 3%, n ϭ 4) and for CD4 ϩ CD25 ϩ cells was: C57BL/6 (95 Ϯ 4%, n ϭ 4), CD28 deficient (96 Ϯ 3%, n ϭ 3), and CD7/CD28 deficient (91 Ϯ 1%, n ϭ 4). Consistent with the surface phenotype and proliferative potential of regulatory T cells, the isolated CD4 ϩ CD25 ϩ cells used in in vitro assays were CD69 Ϫ CD44 int , displayed a memory phenotype of CD62L Ϫ CD45RB Ϫ , and were anergic when stimulated with Con A or T cell-depleted accessory cells plus anti-CD3 in vitro (data not shown).
Isolation of T cell-depleted accessory cells
Single-cell suspensions of RBC-depleted splenocytes from each mouse strain (e.g., wild-type, CD7 deficient, CD28 deficient, CD7/CD28 double deficient) were isolated as indicated above. Splenocytes were incubated with a mixture of biotin-conjugated Abs (CD45R, DX5, CD11b, and Ter-119) and anti-biotin microbeads (Pan T Cell Isolation kit; Miltenyi Biotec). Cells were washed, resuspended in 500 l of MACS buffer, and placed over an MS column. T cell-depleted splenocytes were eluted from the MS column with MACS buffer, counted, and resuspended in complete medium to a final concentration of 1 ϫ 10 6 cells/ml before irradiation (3000 rad).
Regulatory T cell functional assays
The suppressive properties of the CD4 ϩ CD25 ϩ phenotype T cells were demonstrated for each mouse strain according to previously published methods utilizing an accessory cell-dependent proliferation assay that was augmented by CD3 triggering (26, 27) . Briefly, CD4 ϩ CD25 Ϫ (responders) cells were cultured in 96-well round-bottom plates (final volume, 200 l) with accessory cells (stimulators), 0.5 g/ml purified anti-CD3 (2C11), and the indicated number of either CD4 ϩ CD25 ϩ cells or CD4 ϩ CD25 Ϫ cells (regulators and cell-density control cells, respectively). The plates were incubated at 37°C in 7% CO 2 for 3 days. Cultured cells were pulsed with [ 3 H]thymidine (1 Ci/well; NEN, Boston, MA) for the final 6 h of culture and tritium incorporation was measured as described previously (15, 17) . Percent suppression was calculated by the formula: percent suppression ϭ 1 Ϫ (cpm with CD4 ϩ CD25 ϩ T cells added)/(cpm with CD4 ϩ CD25 Ϫ T cells added) ϫ 100.
Phenotypic analysis of lymphocytes by flow cytometry
Single-cell suspensions of lymph node cells and splenocytes were analyzed by flow cytometry as described elsewhere (15, 17) .
Mitogen proliferation assays
Mitogen proliferation assays were performed as described previously (15, 17) .
LPS-induced shock
Endotoxic shock was induced in 8-to 10-wk-old male mice by i.p. injection of low-dose LPS plus D-galactosamine (D-gal; 3 Sigma-Aldrich, St. Louis, MO) as previously described (16) . Animals received 1 g LPS and 8 mg D-gal in 0.5 ml of saline. For time course experiments, blood was taken from the retro-orbital plexus under anesthesia. Sera were stored at Ϫ20°C for cytokine determinations.
Cytokine ELISA
Quantification of murine IFN-␥ and TNF-␣ present in mouse serum was determined using commercial cytokine-specific ELISA kits (Genzyme, Cambridge, MA).
Histological examination of thyroids
Thyroids were harvested at sacrifice from aged cohorts of wild-type, CD7deficient, CD28-deficient, and CD7/CD28-double-deficient mice. Tissue was fixed in Formalin, embedded in paraffin, and sectioned. Tissue sections were stained with H&E or immunohistochemically stained with anti-CD3 or anti-mouse Ig (DakoCytomation, Carpinteria, CA) as previously described (28) . Slides were subjected to microscopic examination and photographed. The presence of thyroiditis was determined based on the degree of leukocyte infiltration and thyroid follicle destruction.
Statistics
Student's t test was used to determine p values at a two-tailed level.
Results

CD7/CD28-double-deficient mice have normal levels of CD4 ϩ and CD8 ϩ peripheral T cells
To evaluate CD7/CD28-double-deficient peripheral lymphoid cells, we determined the percentage and absolute number of CD4 ϩ and CD8 ϩ T cells in splenocytes from C57BL/6 wild-type, CD7deficient, CD28-deficient, and CD7/CD28-double-deficient mice. No significant differences were observed in spleen histology nor frequency of splenocyte populations (B cells or myeloid cells) among the four groups of animals studied (data not shown). Analysis of absolute numbers of splenocytes, T cells, and T cell subsets indicated normal levels of CD3 ϩ , CD4 ϩ , and CD8 ϩ T cells in CD7/CD28-double-deficient mice compared with wild-type, CD7-, or CD28-single-deficient animals ( Fig. 1 ).
CD7/CD28-double-deficient mice have decreased B7.1-and B7.2-expressing APCs in spleen
We next determined whether CD7/CD28-double-deficient mice had normal levels of B7.1 and B7.2-expressing cells in spleen. We found that CD28-deficient and CD7/CD28-double-deficient mice had decreased B7.2 ϩ spleen cells compared with wild-type mice, and CD7/CD28-double-deficient mice had decreased numbers of B7.1 ϩ as well as B7.1/B7.2-double-positive spleen cells compared with wild-type mice ( Table I) .
Addition of CD7 deficiency to CD28 deficiency had no effect on in vitro splenocyte proliferative responses to Con A, LPS, or anti-CD3 plus anti-CD28
Mitogenic responses of freshly isolated splenocytes from wildtype, CD7-, CD28-, and CD7/CD28-deficient mice were next ex-amined to determine the impact of CD7 deficiency on CD28 deficiency regarding T cell activation assays. Similar to data reported for CD28-deficient mice (23), we found both CD28-deficient and CD7/CD28-deficient splenocytes had significantly reduced proliferative responses to Con A ( Fig. 2A ), anti-CD3 alone, or anti-CD3 plus anti-CD28 triggering ( Fig. 2C ) compared with wild-type mice ( p Յ 0.05) and compared with CD7-deficient mice ( p Յ 0.05). In contrast, no significant differences in splenocyte proliferation among the four mouse strains were observed with LPS stimulation (Fig. 2B ). These observations suggest that neither CD7 nor CD28 play a role in modulating LPS-induced signaling resulting in splenocyte proliferation. It is important to note that unlike the T cell mitogens Con A and anti-CD3, it is possible that the LPSresponsive cells in our in vitro proliferation assays are B cells and are therefore unaffected by the absence of CD7 or CD28. Taken together, these data demonstrated that combined disruption of CD7 and CD28 did not alter the splenocyte proliferative response to LPS, nor did the addition of CD7 deficiency to CD28 deficiency modulate the reduced proliferative response of CD28-deficient splenocytes to Con A or CD3 triggering.
CD7/CD28 double deficiency partially rescued impaired in vivo cytokine responses to LPS seen in single gene-deficient mice
Since both CD7-deficient and CD28-deficient mice are resistant to endotoxin shock (16, 29) , we studied CD7/CD28-double-deficient mice in a lethal low-dose LPS endotoxic shock model ( Fig. 3 ). As previously reported for this model, 72 h after i.p. injection with 8 mg D-gal and 1 g LPS, 20% of C57BL/6 wild-type animals (n ϭ 10) remained alive (16) . CD7-deficient, CD28-deficient and CD7/ CD28-double-deficient mice were fully resistant to the LPS/D-gal challenge, with 100% of the animals in each group surviving after 72 h (n ϭ 10/group; p Ͻ 0.005 vs wild type). LPS/D-gal induced a peak serum TNF-␣ response at 2 h ( Fig. 3A ) and a peak serum IFN-␥ response at 6 h ( Fig. 3B ) in wild-type control animals (16) . Peak serum TNF-␣ responses in CD7-and CD28-single-deficient mice were significantly reduced vs wild-type mice ( p Ͻ 0.05). There was a complete abrogation of serum IFN-␥ response in CD7-and CD28-single-deficient mice ( p Ͻ 0.05 vs wild type).
CD7/CD28-double-deficient mice also had significantly blunted peak serum TNF-␣ and IFN-␥ responses vs wild-type control ( p Ͻ 0.05); however, double-deficient animals had significantly greater peak serum TNF-␣ and IFN-␥ responses when compared with single-deficient control animals ( p Ͻ 0.05; Fig. 3 ). Although no difference was seen in in vitro responsiveness of splenocytes from the single-and double-deficient mice to LPS (Fig. 2) , the in vivo response to LPS was significantly enhanced in double-deficient mice compared with CD28-single-deficient mice. These data support the hypothesis that signals from CD7 and CD28 are required for LPSinduced cytokine production but not proliferation. The cells involved in LPS-induced proliferation are distinct from the cells producing in vivo cytokines in response to LPS. In this regard, in the FIGURE 1. Quantitation of peripheral T cell subsets in CD7-deficient, CD28-deficient, and CD7/CD28-double-deficient mice. Splenocytes were isolated from all four strains, counted, and surface marker expression analyzed by flow cytometry. Absolute number of T cells or T cell subsets was determined by multiplying the total number of splenocytes by the frequency of CD3 ϩ , CD3 ϩ CD4 ϩ , or CD3 ϩ CD8 ϩ T cells (CD3 ϩ gate). Data are mean Ϯ SEM. low-dose LPS shock model, IFN-␥ and TNF-␣ production by liver NK-T cells has been shown to be critical for the induction of the shock syndrome (30) . In addition, in CD7-deficient mice, this population is markedly decreased (16) . Therefore, in vitro LPS proliferation does not reflect the abnormalities that lead to defective cytokine production in vivo in CD7-or CD7/CD28-deficient mice. A possible mechanism for the partial restoration of cytokine production in response to LPS (Fig. 3) is a reduction of circulating T regulatory cells in the double-deficient animals. Loss of T regulatory cell suppression may result in increased in vivo cytokine responses to LPS. Therefore, analysis of T regulatory cell number and function in the four strains of animals was next examined.
CD7/CD28-double-deficient mice have reduced numbers of CD4 ϩ CD25 ϩ regulatory phenotype T cells in thymus and spleen
We have previously reported that CD7/CD28-double-deficient mice have a significantly reduced density of CD25 on thymocyte subsets (17) . To determine whether peripheral T cells also express diminished CD25, the median fluorescence intensity of CD25 expression on freshly isolated splenic CD4 ϩ and CD8 ϩ T cells (CD3 ϩ ) was quantitated (Fig. 4A ). There were no significant differences in CD25 expression on CD8 ϩ peripheral T cells from CD7-or CD28-single-deficient mice nor CD7/CD28-double-deficient mice. However, analysis of CD25 expression on CD4 ϩ peripheral T cells revealed significantly lower CD25 expression in the CD4 ϩ T cell compartment from CD28-deficient vs wild-type mice ( p Յ 0.05) and on CD4 ϩ splenic T cells from CD7/CD28double-deficient mice vs either wild-type, CD7-single-deficient or CD28-single-deficient mice ( p Յ 0.05). Representative two-parameter histograms of CD3 ϩ gated splenocytes show that this loss of CD25 staining may be due to a loss in the frequency of CD25 ϩ CD4 ϩ T cells in these animals (Fig. 4B) .
The thymus is the source of CD4 ϩ CD25 ϩ T regulatory cells in early life. These cells reside in the CD3 ϩ , CD4-single-positive (CD4SP) thymocyte compartment (21) . First, we determined the absolute number of CD3 ϩ CD4SPCD25 ϩ thymocytes in wild-type, CD7-deficient, CD28-deficient, and CD7/CD28-double-deficient mouse thymuses (Fig. 4A ). We found significantly decreased absolute numbers of CD3 ϩ CD4SPCD25 ϩ thymocytes in CD7/CD28-doubledeficient mice compared with wild-type and compared with CD7-or CD28-single-deficient mice ( p Յ 0.004; Fig. 4C ).
Next, the absolute number of CD4 ϩ CD25 ϩ T cells was evaluated in the periphery of the four mouse strains (Fig. 4D) . The absolute number of CD4 ϩ CD25 ϩ T regulatory phenotype cells in spleen was significantly decreased in both CD28-deficient and CD7/CD28-double-deficient mice compared with wild-type mice ( p Յ 0.05). Furthermore, CD7/CD28-double-deficient mice had significantly lower numbers of CD4 ϩ CD25 ϩ T cells per spleen when compared with either CD7-or CD28-single-deficient mice ( p Յ 0.004 Fig. 4D ). Thus, the combined deficiency of both CD7 and CD28 resulted in decreased numbers of CD4 ϩ CD25 ϩ regulatory phenotype T cells in thymus and spleen. Splenocytes were isolated and cultured with either Con A (A) or LPS (B) for 3 days at 10 6 cells/ml as described in Materials and Methods. C, Splenocytes were cultured with medium alone, anti-CD3 only, anti-CD28 only, or anti-CD3 plus anti-CD28 for 3 days at 10 6 cells/ml as described in Materials and Methods. Data are expressed in cpm/10 6 splenocytes. Data are mean cpm/10 6 splenocytes Ϯ SEM of three age-matched male mice and are representative of two to three separate experiments. ‫,ء‬ p Յ 0.05 vs C57BL/6 and CD7-deficient mice. 
CD4 ϩ CD25 ϩ T cells from CD7/CD28-deficient mice have present but decreased in vitro suppressive function
To evaluate the functional properties of CD4 ϩ CD25 ϩ T cells in CD7-deficient, CD28-deficient, and CD7/CD28-double-deficient mice, we used a CD3 triggering assay previously described by Thornton and Shevach (Refs. 26 and 27 and Fig. 5 ). Lymph node CD4 ϩ CD25 Ϫ T cells were stimulated to proliferate in the presence of irradiated accessory cells (T cell-depleted splenocytes) plus anti-CD3 mAb (2C11). Lymph node T regulatory phenotype cells (CD4 ϩ CD25 ϩ ) were then added in different ratios vs CD4 ϩ CD25 Ϫ control cells to determine percent suppression.
We found that the dose-dependent suppressive capability of CD4 ϩ CD25 ϩ T cells from CD7-deficient mice was comparable to that of wild-type mice in assays with autologous responders, stimulators, and regulators (Fig. 5A ). However, responder CD4 ϩ CD25 Ϫ T cells isolated from either CD28-single-deficient or CD7/CD28-double-deficient animals gave weak proliferative responses to CD3 mAb that prevented evaluation of suppressive effects of isolated CD4 ϩ CD25 ϩ T cells from CD28-and CD7/ CD28-deficient mice (Fig. 2C and Ref. 23 ).
To circumvent this complication, we tested the ability of CD4 ϩ CD25 ϩ T regulatory cells from CD28-deficient and CD7/ CD28-double-deficient mice for their ability to suppress CD4 ϩ CD25 Ϫ T cells from C57BL/6 wild-type mice triggered with accessory cells plus CD3 mAbs (Fig. 4B ). CD4 ϩ CD25 ϩ cells from either CD28-single-deficient or CD7/CD28-double-deficient mice were added to wild-type CD4 ϩ CD25 Ϫ responder T cells mixed with wild-type irradiated accessory cells plus anti-CD3 mAb. Percent suppression for lymph node T regulatory cells in this assay are shown in Fig. 5B . Now with a robust CD4 ϩ CD25 Ϫ wild-type T cell proliferative response, we were able to evaluate the suppres-sive capabilities of CD28-single-deficient and CD7/CD28-doubledeficient CD4 ϩ CD25 ϩ T cells vs wild-type CD4 ϩ CD25 ϩ T cells. At the highest cell concentrations of CD4 ϩ CD25 ϩ T cells from CD28-single-deficient and CD7/CD28-double-deficient mice (1:1 or 1:2 cell ratios), the suppressive effects were not statistically different from those of CD4 ϩ CD25 ϩ T cells from wild-type mice, showing that the CD4 ϩ CD25 ϩ T cells present in CD28-deficient and CD7/CD28-double-deficient mice had measurable suppressive activity. However, at the lowest ratio of CD4 ϩ CD25 ϩ to CD4 ϩ CD25 Ϫ cells (1:10), CD7/CD28-deficient CD4 ϩ CD25 ϩ T cell suppressive activity was significantly less than wild-type and CD28-single-deficient CD4 ϩ CD25 ϩ T cells (Fig. 5B ), suggesting decreased potency of CD7/CD28-double-deficient lymph node T regulatory cells.
Because the CD4 ϩ CD25 ϩ T regulatory cell populations used in the experiments in Fig. 4B from CD28-single-deficient and CD7/ CD28-double-deficient mice were magnetic bead enriched and were Ͻ90% pure, the data in Fig. 4B may not adequately analyze the potency of CD7/CD28-deficient T regulatory cells compared with wild-type cells. Thus, we determined in vitro suppressive activity with FACS-purified wild-type, CD28-deficient, and CD7/ CD28-double-deficient lymph node CD4 ϩ CD25 ϩ T cells (Fig.  5C ). With highly purified populations of both CD4 ϩ CD25 Ϫ responders and CD4 ϩ CD25 ϩ T regulatory cells in the assay (C57BL/6 CD4 ϩ CD25 ϩ cells ϭ 95 Ϯ 4%, CD28-deficient CD4 ϩ CD25 ϩ cells ϭ 98 Ϯ 2%, and CD7/CD28-deficient CD4 ϩ CD25 ϩ cells ϭ 91 Ϯ 1%), we observed statistically significant less suppression of CD3-triggered CD4 ϩ CD25 Ϫ T cell activation by CD28-deficient and CD7/CD28-double-deficient CD4 ϩ CD25 ϩ cells compared with wild-type control assays. This was apparent at CD4 ϩ CD25 ϩ to CD4 ϩ CD25 Ϫ cell ratios of 1:10, splenocytes from the four strains of mice. C, Freshly isolated thymocytes from C57BL/6 wild-type and CD7-, CD28-, and CD7/CD28-deficient mice were phenotyped by flow cytometry (CD3/CD4/CD8/CD25). Ten thousand events were analyzed per thymocyte preparation to determine the frequency of CD3 ϩ , CD4SP, CD25 ϩ cells. The number of CD3 ϩ CD4SP/CD25 ϩ T regulatory phenotype cells was calculated using the absolute number of thymocytes isolated from each animal. D, Freshly isolated splenocytes from wild-type and CD7-, CD28-, and CD7/CD28-deficient mice were phenotyped as above. Data are mean Ϯ SEM (n ϭ 3/group). ‫,ء‬ p Յ 0.05 vs C57BL/6; †, p Յ 0.05 vs C57BL/6, CD7-deficient and CD28-deficient mice. 1:5, and 1:2 (Fig. 5C ). There were no significant differences in percent suppression between the CD28-and CD7/CD28-deficient groups. These data indicated that significantly more T regulatory cells were required from CD28-or CD7/CD28-deficient mice to achieve a comparable level of in vitro suppression to that from wild-type mice, thus confirming decreased potency of CD28-deficient and CD7/CD28-double-deficient lymph node T regulatory cells compared with wild-type T regulatory cells. These data suggest no additive impact of CD7 deficiency to the potency of CD28deficient CD4 ϩ CD25 ϩ T regulatory cells.
Aged CD7/CD28-double-deficient mice develop spontaneous thyroiditis
CD4 ϩ T regulatory cells are reported to regulate peripheral levels of CD4 ϩ T cells and to suppress organ-specific autoimmune disease (21) . Neither CD7-deficient, CD28-deficient, nor CD7/CD28double-deficient mice (6 -119 wk) presented with elevated levels of peripheral CD4 ϩ T cells, shortened life span, decreased reproduction, or weight loss (data not shown). However, histologic analysis of the thyroid gland from aged (55-119 wk) C57BL/6 wildtype, CD7-deficient, CD28 deficient-, and CD7/CD28-doubledeficient animals revealed spontaneous thyroiditis in 50% of the CD7/CD28-deficient mice compared with none in age-matched wild-type or control animals ( p Յ 0.003; Table II and Fig. 6 ). Representative H&E-stained sections from the four strains of mice are shown in Fig. 6 , A-D. Thyroid tissue sections from affected CD7/CD28-double-deficient mice were immunohistochemically stained with anti-CD3 and anti-mouse Ig to characterize lymphocytes in the leukocyte infiltrate. Both CD3 ϩ T cells and intracytoplasmic Ig ϩ B cells were detected in the inflamed thyroid tissues of aged CD7/CD28-double-deficient mice (Fig. 6, D and E, respectively) . These data suggested that in vivo loss of peripheral T regulatory cells allowed for the development of spontaneous thyroiditis in the CD7/CD28-double-deficient mouse model.
Discussion
In this study, we have shown that CD7/CD28-double-deficient mice have decreased numbers of thymus CD4 ϩ CD25 ϩ T regulatory cells compared with CD7-single-deficient, CD28-single-deficient, and wild-type mice. Similarly, we found that CD7/CD28double-deficient mice had decreased numbers of peripheral splenic CD4 ϩ CD25 ϩ T cells and significantly reduced numbers of B7.1 ϩ as well as B7.1/B7.2-double-positive splenocytes compared with control animals. We demonstrated that CD28-deficient and CD7/ CD28-double-deficient CD4 ϩ CD25 ϩ T cells were less potent suppressors of CD3-triggered CD4 ϩ CD25 Ϫ T cells compared with those from wild-type mice. Lastly, we reported for the first time that aged CD7/CD28-double-deficient mice develop spontaneous FIGURE 5. T regulatory cells from CD7/CD28-double-deficient mice have reduced suppressive function. A, Ability of enriched CD4 ϩ CD25 ϩ lymph node T cells from either C57BL/6 or CD7-deficient mice to suppress autologous CD4 ϩ CD25 Ϫ T cell proliferative responses to irradiated accessory cells plus CD3 mAb as described in Materials and Methods. Plotted are the mean percent suppression Ϯ SEM. Mean peak [ 3 H]thymidine responses of CD4 ϩ CD25 Ϫ T cells to CD3 mAb was 499,244 cpm/10 6 cells for C57BL/6 and 497,947 cpm/10 6 cells for CD7-deficient mice. B, C57BL/6 CD3 triggered base MLR to assess the in vitro potency of T regulatory cells from CD28-deficient and CD7/CD28-double-deficient mice (see Materials and Methods). Peak [ 3 H]thymidine response of CD4 ϩ CD25 Ϫ cells to CD3 from C57BL/6 cells was 499,244 cpm/10 6 cells, from CD28-deficient mice was 454,331 cpm/10 6 cells, and from CD7/ CD28 deficient mice was 242,865 cpm/10 6 cells. Plotted are the mean percent suppression Ϯ SEM. ‫,ء‬ p Յ 0.05 vs C57BL/6; †, p Յ 0.05 vs CD28-deficient mice. C, FACS-sorted T regulatory phenotype cells from CD7/CD28-double-deficient mice have decreased suppressive function compared with C57BL/6 mouse-derived T regulatory phenotype cells (see Materials and Methods). Plotted are the mean percent suppression Ϯ SEM. The peak [ 3 H]thymidine response to CD3 mAb of CD4 ϩ CD25 Ϫ cells from C57BL/6 was 133,062 cpm/10 6 cells, from CD28-deficient mice was 291,972 cpm/10 6 , and from CD7/CD28-deficient mice was 394,872 cpm/ 10 6 cells. ‫,ء‬ p Յ 0.05 vs C57BL/6. thyroiditis, with T and B cell infiltrates, where as age-matched CD7-single-deficient, CD28-single-deficient, and wild-type mice did not.
The observation that CD7-and CD28-single-deficient mice had normal numbers of thymic CD4 ϩ CD25 ϩ T cells in our study suggested that thymic production of T regulatory cells is not exclusively dependent on either CD7 or CD28. However, the combined deletion of both CD7 and CD28 significantly decreased the absolute number of thymic T regulatory phenotype cells. We recently reported that CD7 and CD28 deficiencies combined to produce decreased thymocyte IL-2R expression and decreased numbers of B7.1/B7.2-expressing cells in the thymus (17) . Together, these findings suggest a cooperative role for CD7 and CD28 in thymic production and/or maintenance of CD4 ϩ CD25 ϩ T regulatory cells. It has been shown that CTLA-4-Ig administration to nonobese diabetic mice depletes the thymus of CD4 ϩ CD25 ϩ T cells, suggesting that CD28 engagement by B7.1/B7.2 is critical for thymic production of CD4 ϩ CD25 ϩ T cells (31) . One hypothesis is that loss of CD7-CD7 ligand interactions combined with loss of CD28-B7.1/B7.2 interactions leads to lack of generation and/or survival of CD4 ϩ CD25 ϩ T cells in the thymus.
Although it has been previously reported that CD28-deficient mice have decreased numbers of peripheral CD4 ϩ CD25 ϩ T cells (22) , our study showed that addition of CD7 deficiency to CD28 deficiency added to this phenotype and further decreased the peripheral number of CD4 ϩ CD25 ϩ T cells in the double-deficient animals. In addition, we demonstrated that deletion of both CD7 and CD28 results in significantly reduced numbers of B7.1 ϩ and B7.1/B7.2-double-positive splenocytes.
Three mechanisms have been postulated to reduce peripheral CD4 ϩ CD25 ϩ T cell levels: decreased T regulatory cell production in the thymus, increased peripheral CD4 ϩ CD25 ϩ T cell apoptosis rates, and increased conversion of CD4 ϩ CD25 ϩ cells to CD4 ϩ CD25 Ϫ cells in the periphery (18, 31) . Specifically, it has been shown that CD80/CD86, CD28, and IL-2 deficiency all result in marked decreases in survival of peripheral CD4 ϩ CD25 ϩ T regulatory cells (18) . In our study, CD28-deficient CD4 ϩ CD25 ϩ T cells are produced at normal levels in the thymus but then fail to thrive in the periphery. The ability of CD7/CD28-double-deficient CD4 ϩ CD25 ϩ T cells to survive in the periphery is further hampered by the absence of CD7. Since IL-2 is required for CD4 ϩ CD25 ϩ T cell generation and survival (32) , it is reasonable to postulate that decreased CD4 ϩ CD25 ϩ cell survival in CD7/ CD28-double-deficient mice may be attributed to a loss of IL-2 production due to lack of CD7 and CD28 engagement. It is also possible that CD4 ϩ CD25 ϩ T cells, which constitutively express CTLA-4 (22, 33) , may be delivered an apoptotic signal by B7.1/ B7.2 in the absence of CD28, thereby depleting the periphery of T regulatory phenotype cells. The additional loss of CD7-derived survival signals may further exacerbate the neglect of CD4 ϩ CD25 ϩ T cells in the periphery of CD7/CD28-deficient animals.
Analysis of lymph node CD4 ϩ CD25 ϩ T cells in CD7/CD28deficient mice revealed intact suppressor cell function for CD3 mAb-triggered C57BL/6 CD4 ϩ CD25 Ϫ T cells. However, CD4 ϩ CD25 ϩ T cells from CD28-and CD7/CD28-deficient mice were less potent than wild-type CD4 ϩ CD25 ϩ T cells. It has been reported that activated CD4 ϩ CD25 ϩ T cells are more potent than resting CD4 ϩ CD25 ϩ T cells (34) . Therefore, reduced function of CD28-and CD7/CD28-deficient T regulatory cells may be attributed to a lack of activation due to decreased IL-2 responsiveness and absence of CD7 ligand and B7.1/B7.2 triggering in vivo. It will be important to determine whether CD7/CD28-deficient T regulatory cells have an activation defect to explain their diminished potency as suppressor T cells.
CD4 ϩ T regulatory phenotype cells modulate peripheral levels of CD4 ϩ T cells and are known to suppress organ-specific autoimmune disease (21) . Therefore, we analyzed 1-to 2-year-old mice to determine whether the reduced numbers and potency of T regulatory cells in CD7/CD28-deficient animals resulted in the spontaneous development of autoimmune disease. Compared with age-matched wild-type and single gene-deficient animals, there were no outward signs of autoimmune disease such as hair loss, rashes, weight loss, decreased reproduction, etc. However, we observed significant thyroiditis with T and B cell infiltrate in aged CD7/CD28-double-deficient mice that was not seen in agematched control mice. Thus, the combined deficiency of CD7 and CD28 resulted in the loss of T regulatory cells and allowed for the spontaneous development of thyroiditis in animals Ͼ1 year of age. Seddon and Mason (35) have previously shown in a rat thymectomy/irradiation model of autoimmune thyroiditis that disease can be suppressed by transfer of T regulatory phenotype cells (35) . Together, these findings suggest that in vivo loss of peripheral T regulatory cells due to deletion of both CD7 and CD28 allows for the development of spontaneous thyroiditis.
In addition to the development of thyroiditis only in CD7/CD28double-deficient mice, the other key differences between CD28deficient and CD7/CD28-double-deficient mice in our study were that the CD7/CD28-double-deficient mice had a more profound deficiency in absolute numbers of peripheral CD4 ϩ CD25 ϩ T cells FIGURE 6. Thyroiditis with T and B cell infiltrate is present in aged CD7/CD28double-deficient mice, but not age-matched control animals. A, H&E-stained C57BL/6 wild-type thyroid tissue. B, H&E-stained CD7-deficient thyroid tissue. C, H&Estained CD28-deficient thyroid tissue. D, H&E-stained CD7/CD28-double-deficient thyroid tissue. E, CD7/CD28-doubledeficient thyroid tissue stained with anti-CD3. F, CD7/CD28-double-deficient thyroid tissue stained with anti-mouse Ig. Brown stain within thyroid follicles (E and F, labeled with an ‫)ء‬ is nonspecific and was in control sections. Arrows point out CD3 ϩ T cells (E) and intracytoplasmic Ig ϩ B cells (F). All sections were photographed at the same magnification. A 100-m bar is placed in F for reference. compared with CD28-deficient mice and they had low numbers of thymus CD4 ϩ CD25 ϩ T cells, whereas CD28-deficient mice had normal numbers of these cells in the thymus. We also observed a significant enhancement of in vivo cytokine responses to LPS in CD7/CD28-double-deficient mice. It will be important to determine whether this enhancement is related to the deficiency of CD4 ϩ CD25 ϩ T cells in these mice.
In summary, our data provide new evidence for a role for CD7-CD7 ligand interactions in thymic and peripheral homeostasis of CD4 ϩ CD25 ϩ regulatory T cells. Understanding the roles of CD7 and CD28/CTLA-4 in regulating T regulatory cell growth and persistence in this novel model should provide important insight into the molecular mechanisms of regulation of normal immune responses and autoimmune disease.
